neurogenic diabetes insipidus due to brain diseases or head injury. Diabetes insipidus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hospitalization in the intensive care unit Having diagnostic criteria for diabetes insipidus Signing the informed consent form by the patient's family Establishment of enteral nutrition Not having drug interactions with the drugs received by the patient based on the opinion of traditional medicine pharmacist colleagues
Exclusion criteria
Exclusion criteria: Discontinuation of enteral feeding for any reason Death of the patient due to various causes Patient discharge Declaration of non-consent by the patient's family to continue the plan The occurrence of drug interactions with the drugs received by the patient based on the opinion of traditional medicine pharmacist colleagues
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's urine volume during 24-hour. Timepoint: 24-hour urine volume measurement at the beginning of the study (before the start of the intervention) and 24 and 48 and 72 hours after the administration of placebo, honey-frankincense or honey-ginger combination. Method of measurement: 24-hour urine volume measurement by graduated urine bags connected to the patient's Foley catheter daily (every 24 hours). | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum sodium level. Timepoint: Serum sodium level measurement at the beginning of the study (before the start of the intervention) and 24 and 48 and 72 hours after the administration of placebo, honey-frankincense or honey-ginger combination. Method of measurement: Laboratory measurement on blood sample by biochemistry autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ahvaz University of Medical Sciences